Internal Medicine, Hematology & Oncology · Englewood, CO
NPI
1255667655
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
701 E Hampden Ave Ste 300
Englewood, CO, 80113
Phone (303) 740-8200
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
174,457 services
Medicare patients, 2024
665
Average age 74
Drug cost, 2024
$11.8M
1,866 prescriptions
Company payments, 2025
$118K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher B Benton was code J0896 (injection, luspatercept-aamt, 0.25 mg), 31,975 times for 20 patients. In total Christopher B Benton billed 174,457 services in 190 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0896 Injection, luspatercept-aamt, 0.25 mg | Office | 31,975 | 20 | $31.07 | $993K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 13,638 | 18 | $2.32 | $32K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,050 | 26 | $0.11 | $777 |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,600 | 20 | $0.17 | $1,093 |
| J0185 Injection, aprepitant, 1 mg | Office | 5,590 | 14 | $1.35 | $7,535 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,405 | 50 | $0.10 | $448 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 4,200 | 12 | $44.23 | $186K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,596 | 15 | $36.90 | $133K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,000 | 22 | $15.78 | $47K |
| 85025 Blood Count | Office | 1,828 | 289 | $7.57 | $14K |
| 36415 Venipuncture Blood Collection | Office | 1,704 | 292 | $8.62 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,360 | 51 | $0.09 | $123 |
| 80053 Clinical Chemistry | Office | 1,346 | 249 | $10.31 | $14K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,020 | 40 | $0.71 | $725 |
| 88185 Surgical Pathology Examination | Office | 943 | 34 | $19.32 | $18K |
By year: 2022 $2.2M for 200,515 services; 2023 $3.1M for 223,933 services; 2024 $2.9M for 174,457 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,828 | 289 | $7.57 | $14K |
| 36415 Venipuncture Blood Collection | 1,704 | 292 | $8.62 | $15K |
| 80053 Clinical Chemistry | 1,346 | 249 | $10.31 | $14K |
| 88185 Surgical Pathology Examination | 943 | 34 | $19.32 | $18K |
| 82784 Immunoassay | 336 | 50 | $9.11 | $3,062 |
| 83540 Clinical Chemistry | 311 | 142 | $6.32 | $1,966 |
| 83550 Clinical Chemistry | 311 | 142 | $8.54 | $2,657 |
| 82728 Clinical Chemistry | 311 | 142 | $13.32 | $4,143 |
| 85610 Clinical Chemistry | 190 | 12 | $4.20 | $798 |
| 83615 Clinical Chemistry | 107 | 84 | $5.87 | $628 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher B Benton prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 343 prescriptions and refills. In total Christopher B Benton wrote 1,866 Medicare prescriptions that cost $11.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 343 | 343 | 44 | $5.7M |
| Warfarin Sodium Generic | 189 | 347 | 27 | $996 |
| Eliquis Apixaban | 187 | 268 | 34 | $156K |
| Xarelto Rivaroxaban | 169 | 267 | 35 | $154K |
| Valacyclovir Valacyclovir Hcl | 106 | 156 | 28 | $5,409 |
| Hydroxyurea Generic | 79 | 160 | 22 | $1,698 |
| Revlimid Lenalidomide | 60 | 60 | Under 11 | $820K |
| Ojjaara Momelotinib Dihydrochloride | 58 | 58 | Under 11 | $1.6M |
| Venclexta Venetoclax | 52 | 52 | 17 | $61K |
| Inqovi Decitabine/Cedazuridine | 43 | 43 | Under 11 | $192K |
| Vonjo Pacritinib Citrate | 39 | 39 | Under 11 | $760K |
| Levofloxacin Generic | 35 | 37 | 19 | $263 |
| Cefpodoxime Proxetil Generic | 28 | 32 | Under 11 | $5,263 |
| Scemblix Asciminib Hydrochloride | 26 | 26 | Under 11 | $512K |
| Enoxaparin Sodium Generic | 23 | 23 | 12 | $3,082 |
Brand drugs: 1,086 claims; generic drugs: 780 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher B Benton $118K ($118K in general payments such as food, travel and fees) from 24 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $29K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $29K |
| GlaxoSmithKline, LLC. GSK | 15 | $17K |
| Geron Corporation GERN | 9 | $13K |
| Sobi, Inc SOBI.ST | 8 | $12K |
| Alexion Pharmaceuticals, Inc. AZN | 9 | $11K |
| Novartis Pharmaceuticals Corporation NVS | 7 | $11K |
| Incyte Corporation INCY | 10 | $9,456 |
| Syndax Pharmaceuticals, Inc. SNDX | 10 | $8,963 |
| Genzyme Corporation SNY | 2 | $3,489 |
| Taiho Oncology, Inc. 4578.T | 1 | $2,100 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.